This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
John Bel Edwards has signed a series of bills into law greatly expanding patients ability to access medical cannabis products. ” Under the current law , doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer.
House lawmakers have overwhelmingly approved two bills to amend the state’s medical marijuana program in a manner that significantly expands patients’ access to cannabis products. The measure establishes regulations permitting the home delivery of medical cannabis products to registered patients.
"Passage of this legislation will provide qualified patients with a state-sanctioned option to access a therapy that has proven to offer significant benefits." The post Texas: House Lawmakers Advance Legislation Expanding Access to Medical Cannabis Products appeared first on NORML.
1647 , the Veterans Equal Access Act, which expands medical cannabis access to eligible military veterans. Blumenauer said, “For too long, our veterans have been denied access to highly effective medical marijuana treatment for conditions like chronic pain and PTSD. Presently, V.A. At the time of introduction, Rep.
Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.
House and Senate lawmakers have approved a series of bills to facilitate patients’ access to medical cannabis products. ” Under the current law, doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. .” John Bel Edwards.
Legislation will take effect next week expanding protections for state-qualified medical cannabis patients. It strengthens patient protections by explicitly stipulating that registered cannabis consumers may not be denied public assistance, access to firearms, or certain types of employment solely based upon their patient status.
Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.
This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. Research published in the Journal of Psychoactive Drugs found a 75% reduction in Clinician-Administered Posttraumatic Scale scores following cannabis therapy.
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.
Steve Sisolak has signed legislation, Senate Bill 430 , expanding the pool of patients eligible for medical cannabis therapy. The measure allows patients diagnosed with anxiety disorders, autism, chronic pain, opioid dependency, and other conditions to obtain a recommendation for medical cannabis.
Senators on Wednesday passed legislation to significantly expand the pool of patients eligible to qualify for medical cannabis access. ” Under the current law , doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. .”
Researchers have steadily advanced the field of psychedelic-assisted therapy over the last decade or two. This passage also spurred the development of an eagerly anticipated psychedelic-assisted therapy industry, now ready to see its very first patients very soon. What Does the Colorado Law Legalize Specifically?
A letter from ASA Founder & President The positive impacts of medical cannabis on patients and the healthcare systems that serve them are profound and far-reaching. Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C., and four of the five U.S.
Currently, in the 10 states that have legalized adult use cannabis and the 33 states that have legalized medical marijuana programs, entrepreneurs and small businesses are unable to access the valuable programs and support of the Small Business Administration. Presently, V.A. Passage of either of these bills would lift this prohibition.
Doug Burgum signed legislation on Wednesday amending and expanding the state’s nascent medical cannabis access program. House Bill 1283 permits physician assistants to recommend cannabis to qualified patients.
The CDC’s interest in alternative methods of chronic pain management is likely to be of particular significance to many medical cannabis patients. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5
Enrolling in Oregon's medical marijuana program (OMMP) requires an application, physician and patient documentation, and a fee, but does have benefits. I sat down (virtually of course) with Debbie Churgai, Executive Director of Americans for Safe Access to get some tips and talking points to help patients start this conversation.
State lawmakers have approved a series of bills reducing penalties for marijuana possession offenses and strengthening and expanding legal protections for medical cannabis patients. Senate Bill 406 expands medical cannabis access and provides important new patient protections. The measures now await action from Democratic Gov.
Environmental Factors : Peer pressure, social acceptance of cannabis use, and ease of access can also contribute to the development of CUD. Motivational Enhancement Therapy (MET) : This therapy encourages individuals to build motivation to reduce their cannabis use, focusing on their reasons for wanting to change.
Phil Murphy signed legislation into law today significantly amending and expanding the state’s medical cannabis access program. Assembly Bill 20 , The Jake Honig Compassionate Use Medical Cannabis Act, institutes various changes to the program to better facilitate patients’ access to the substance.
The real stories around medical marijuana (MMJ) are those of the patients who have experienced life-changing benefits from cannabis therapy. The positive impact it’s having on the lives of patients across West Virginia is significant. Cannabis therapy can help reduce anxiety, improve mood, and offer a sense of calm.
Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? AZ resident? California.
Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit patients to grow up to nine cannabis plants in a locked, enclosed facility, and to possess up to three ounces of home-grown medical cannabis. ND resident?
Bronner’s expressed gratitude and excitement for its new partnership with healthcare organization Enthea to expand its employee medical benefits to include psychedelic therapies. Why Psychedelic Therapies? Enthea reports many astounding statistics surrounding psychedelic-assisted therapy studies.
House and Senate lawmakers have approved legislation, House File 732 , to expand the state’s medical cannabis access program. The new measure imposes restrictions regarding the total amount of THC a patient may possess in a 90-day period (25 grams). About 1,000 Iowans are currently authorized to access low-THC cannabis oils.
Both parties to this new relationship are committed to excellence in clinical research and patientaccess to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.
At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. A medical cannabis access bill was signed into law in the U.S. If passed, this bill provides registered patients with regulated access to medical cannabis via licensed providers.
New Mexico: Members of the Senate overwhelmingly (33 to 2) passed SB 406 to expand greater medical access and to limit discrimination in the workplace and elsewhere against qualified patients. The measure, SB 1557 , also permits qualifying patientsaccess to a broader spectrum of products containing both plant-derived CBD and THC.
In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. The FDA refers to this program as the expanded access program on their website. A Push by Patients. Patients Are Not In This Alone.
The measure would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder as well as opioid use disorder. Legislation is pending, House Bill 268 and House Bill 528, to allow those convicted of simple marijuana possession to petition the court to restrict access to their records. GA resident?
It seeks to redefine allowed dosage limitations and formulations, and expand patientaccess and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients. Marijuana policy should be evidence based.
Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder. NORML opposes this legislation. CT resident? CT resident?
Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. About Curaleaf International.
Veteran Access : HR 1647, the Veterans Equal Access Act, would allow V.A. Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Your Highness, Carly.
However, not many patients know the reasons behind how medical marijuana interacts with the body, so we prepared this comprehensive guide to use as a starting point for those considering cannabis treatment. ECS modulation also aids in managing symptoms of nausea and vomiting in cancer patients undergoing chemotherapy. What is ECS?
Canada recently amended its Controlled Drugs and Substances Act (CDSA) to allow for psilocybin and MDMA therapy in limited circumstances. Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions.
Click here to email your lawmakers in support of banking access. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder.
Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.
Forbes report… A young boy and his single mother are in the midst of a 1,000-mile walk across the United Kingdom, a journey they are making to raise awareness and funds to provide medicinal cannabis to chronically ill patients. The walk is also serving as a call to action for the U.K. on Twitter or Facebook.
Cannim will sell its products in the EU medical markets through the Cantourage Fast Track Access Platform. The agreement allows medical cannabis flowers from Jamaica to be made available to German patients for the first time. Cantourage continues to provide innovative cultivars and a safe, diverse supply for patients”.
Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy.
Passage of this legislation is important because the Arizona Court of Appeals recently ruled that patients who rely on these products are not protected under the law and could face felony penalties for simply using their medicine. Click here to email your lawmakers in support of access in healthcare facilities. California. CA resident?
Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response. improvement in good sleep.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content